Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia: A study of 40 early-onset patients

Cancer Genetics and Cytogenetics

Volumn 140, Issue 1, 2003, Pages 31-36

  Doneda, Luisa ^b   Montillo, Marco ^a   Intropido, Liliana ^a   Tedeschi, Alessandra ^a   Morra, Enrica ^a   Larizza, Lidia ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BONE MARROW EXAMINATION; CANCER DIAGNOSIS; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE PROBE; HUMAN; HUMAN TISSUE; INTERPHASE; MALE; MOLECULAR CLONING; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE; YEAST ARTIFICIAL CHROMOSOME;

ADULT; AGE OF ONSET; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; BONE MARROW; CHROMOSOME DELETION; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CLONE CELLS; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE DELETION; GENES, P53; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; ITALY; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; TUMOR STEM CELLS;

EID: 0037238249     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00640-4     Document Type: Article

References (26)

1. Rozman C., Monserrat E. Chronic lymphocytic leukemia. N Engl J Med. 333:1995;1052-1057.
2. Montserrat E., Gomis F., Vallespi T., Rios A., Romero A., Soler J., Alcala A., Morey M., Ferran C., Diaz-Mediavilla J., Flores A., Woessner S., Batlle J., Gonzalez-Aza C., Rovira M., Reverter J.C., Rozman C. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood. 78:1991;1545.
3. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., Pasternak B.S. Clinical staging of chronic lymphocytic leucemia. Blood. 46:1975;219-234.
4. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M.T., Monconduit M., Belabbes S., Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 48:1981;198-206.
5. Juliusson G., Oscier D.G., Fitchett M., Ross F.M., Stockdill G., Mackie M.J., Parker A.C., Castoldi G.L., Guneo A., Knuutila S., Elonen E., Gahrton G. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med. 323:1990;720-724.
6. Juliusson G., Gahrton G. Chromosome aberrations in B-cell chronic lymphocytic leucemia. Pathogenetic and clinical implications. Cancer Genet Cytogenet. 45:1990;143-160.
7. Dohner H., Stilgenbauer S., Dohner K., Bentz M., Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leucemia. reassessment based on molecular cytogenetic analysis J Mol Med. 77:1999;266-281.
8. Stilgenbauer S., Liebisch P., James M.R., Schroder M., Schlegelberger B., Fischer K., Bentz M., Lichter P., Dohner H. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA. 93:1996;11837-11841.
9. Dohner H., Stilgenbauer S., Fischer K., Bentz M., Lichter P. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia. specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes Leukemia. 11:1997;S19-S24.
10. Monni O., Knuutila S. 11q deletions in hematological malignancies. Leuk Lymphoma. 40:2001;259-266.
11. Zhu Y., Monni O., El-Rifai W., Siitonen S.M., Vilpo L., Vilpo J., Knuutila S. Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia. Leukemia. 13:1999;708-712.
12. Neilson J.R., Auer R., White D., Bienz N., Waters J.J., Whittaker J.A., Milligan D.W., Fegan C.D. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival. Leukemia. 11:1997;1929-1932.
13. Dohner H., Stilgenbauer S., James M.R., Benner A., Weilguni T., Bentz M., Fischer K., Hunstein W., Lichter P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood. 89:1997;2516-2522.
14. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., Bigner S.H., Davidson N., Baylin S., Devilee P., Glover T., Collins F.S., Weston A., Modali R., Harris C.C., Vogelstein P. Mutations in the p53 gene occur in diverse human tumour types. Nature. 342:1989;705-708.
15. Gaidano G., Ballerini P., Gong J.Z., Inghirami G., Neri A., Newcomb E.W., Magrath I.T., Knowles D.M., Dalla-Favera R. p53 mutations in human lymphoid malignancies. association with Burkitt lymphoma and chronic lymphocytic leucemia Proc Natl Acad Sci USA. 88:1991;5413-5417.
16. Cano I., Martinez J., Quevedo E., Pinilla J., Martin-Recio A., Rodriguez A., Castaneda A., Lopez R., Perez-Pino T., Hernandez-Navarro F. Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization. association with morphology and resistance to conventional chemotherapy Cancer Genet Cytogenet. 90:1996;118-124.
17. Amiel A., Arbov L., Manor Y., Fejgin M., Elis A., Gaber E., Lishner M. Monoallelic p53 deletion in chronic lymphocytic leucemia detected by interphase cytogenetics. Cancer Genet Cytogenet. 97:1997;97-100.
18. Cordone I., Masi S., Mauro F.R., Soddu S., Morsilli O., Valentini T., Vegna M.L., Guglielmi C., Mancini F., Giuliacci S., Sacchi A., Mandelli F., Foa R. p53 expression in B-cell chronic lymphocytic leukemia. a marker of disease progression and poor prognosis Blood. 91:1998;4342-4349.
19. Dohner H., Fischer K., Bentz M., Hansen K., Benner A., Cabot G., Diehl D., Schlenk R., Coy J., Stilgenbauer S., Volkmann M., Galle P.R., Poutska A., Hunstein W., Lichter P. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood. 85:1995;1580-1589.
20. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S., Rai K.R. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia. revised guidelines for diagnosis and treatment. Blood. 87:1996;4990-4997.
21. ISCN. An international system for human cytogenetic nomenclature. Mitelman F, editor. Basel: S Karger, 1995.
22. De Rossi G., Mandelli F., Covelli A., Luciani M., Martelli M., Resegotti L., Alberti A., Cajozzo A., Deriu L., De Biasi R., Broccia G., Abbadessa A., Baronia F., Leone P. Chronic lymphocytic leukemia (CLL) in younger adults. a retrospective study of 133 cases Hematol Oncol. 7:1989;127-137.
23. Doneda L., Castorina P., Tedeschi A., Intropido L., Morra E., Montillo M., Larizza L. Multicolor FISH in chronic lymphocytic leucemia. An interphase study of patients with early-onset disease. Cancer Genet Cytogenet. 125:2001;63-69.
24. El Rouby S., Thomas A., Costin D., Rosenberg C.R., Potmesil M., Silber R., Newcomb E.W. p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood. 82:1993;3452-3459.
25. Morabito F., Filangeri M., Callea I., Sculli G., Callea V., Fracchiolla N.S., Neri A., Brugiatelli M. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia. correlation with in vitro sensitivity to chlorambucil and purine analogs Haematologica. 82:1997;16-20.
26. Lens D., De Schouwer P.J., Hamoudi R.A., Abdul-Rauf M., Farahat N., Matutes E., Crook T., Dyer M.J., Catovsky D. p53 abnormalities in B-cell prolymphocytic leukemia. Blood. 89:1997;2015-2023.